簡易檢索 / 詳目顯示

研究生: 林敏智
Lin, Min-Chih
論文名稱: 5-氟尿嘧啶衍生物中間體的合成及構形變化的研究
Synthesis and Isomerization studies of Intermediates to 5-Fluorouracil
指導教授: 宋光生
Sung, Kuangsen
學位類別: 碩士
Master
系所名稱: 理學院 - 化學系
Department of Chemistry
論文出版年: 2004
畢業學年度: 92
語文別: 中文
論文頁數: 75
中文關鍵詞: 中間體異構化5-氟尿嘧啶
外文關鍵詞: isomerization, intermediates, 5-Fluorouracil
相關次數: 點閱:61下載:1
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  •   在有機分子結構上,我們經常見到碳-碳雙鍵的形成是很多合成步驟當中的一種。過去30年來,許多的目前的藥物都已經開始著手研發中間體,因為可利用中間體來製備最後的藥物有著較高的效率,所得的產率也較好,也可有效的降低成本。
      我們最初有意利用類似的中間體來合成racil的衍生物,合成的中間體僅得單一一種穩定結構,我們利用gated decoupling 的NMR程式來鑑定分子的conformation,並計算其coupling constant的大小,我們確定中間體分子多以trans 的型態存在較穩定。
      最後我們將製備的中間體,測試uv吸收波長和選定不會對背景產生干擾的溶劑,進行光化學實驗,結果發現vinyl ether中間體在254nm有最大吸收,經過照光的反應後,可由最穩定的trans轉變為較不穩定的cis form,但因自然界趨向於最穩定的狀態,因此在室溫下cis form會緩慢的回去最穩定的狀態,而enamine的中間體也許因為轉動的速度太快,以致於無法順利觀測到。
      此類的中間體分子吸收合適波長的uv光後,雙鍵上的π電子便被激發至perpendicular triplet state,因此分子中取代基原來由共平面的狀態扭曲至平面外,視不同分子有不同的扭曲角度,這類分子的perpendicular triplet state 為次穩定態,視其機率可回到cis form 與trans form的ground state,因此我們便可以看到利用NMR偵測到的結果,這類分子亦可以週而復始的進行結構上的改變,只要給予合適的能量,這類的分子就可被我們加以掌握,如同分子的開關一般。

      Carbon-carbon bond is one of the most important synthetic steps in construction of organic molecules. From now on,many people discuss the intermediate of the Medicine,because it can get more efficiency,more yield,and decrease the cost.
      We want to use the derivative of the intermediate to synthesize 5-fluoro uracil, and get one result of trans or cis form alternatively.By gated decoupling and calculate the coupling constants.We make sure that we get trans compound.
      The intermediate of vinyl ether ,which have a maximum absorption at 254nm.Stable trans form can inverse to unstable cis form under uv irradiation.Cis form can not be isolated,because it will return to trans form.We the intermediate under uv Irradiation,the πelctrons are excited to perpendicular triplet state,and then substituted group of the molecular will twist out of plane.Molecular will release the energy and return to the ground state of cis and trans form.
      The process will regain under uv irradiation,when we provide suitable energy.We can control and regard it as a molecular switch.

    中文摘要………………………………………………………………4 英文摘要………………………………………………………………6 第一章 緒論 1-1 嘧啶環在過去的合成策略回顧………………………………8 1-2 嘧啶的簡介與其在生物醫學上的重要性……………………17 1-3 抗癌藥物的作用與原理………………………………………20 第二章 研究動機…………………………………………………23 第三章 實驗結果與討論 3-1 起始物的合成與中間體的合成………………………………26 3-2 中間體分子結構的鑑定………………………………………34 3-3 中間體分子在UV光化學結構下產生的變化……………….43 第四章 結論與未來展望…………………………………………56 第五章 實驗部分…………………………………………………58 第六章 參考文獻…………………………………………………72

    1.R.R.Hunt,J.F.M.McOmie,and E.R.Sayer,J.Chem.Soc.,1959,525
    2.W.J.Hale,J.Amer.Chem.Soc.,1914,36,104
    3. R.R.Hunt,J.F.M.McOmie,and E.R.Sayer,J.Chem.Soc.,1959,527
    4.C.A.C.Haley and P.Maitland,J.Chem.Soc.,1951,3155
    5.A.von Meyer,J.prakt.Chem.,1889,39,156
    6.R.O.Roblin,J.H.Williams,P.S.Winnek,and J.P.English,J.Amer
    .Chem.Soc.,1940,62,2002
    7.G.W.Kenner and A.Todd,in “Heterocyclic Compounds”,vol.6
    ,ed.R.C.Elderfield,Wiley,New York,1957
    8.H.Bredereck,R.Grompper,H.Schuh,and W.Theilig,Angew Chem.,1959,71,573
    9.H.Rutner and P.E.Spoerri,J.Hetercyclic Chem.,1966,3,435
    10.M.R.Kamal and R.Levine,J.Org.Chem.,1962,27,1355
    11.F.Tutun,J.Chem.Soc.,1910,2495
    12.R.Behrend,H.Meyer,and Buckholz,Annalen,1901,304,200
    13.Chem.Abs.,1942,35,4041
    14.B.Staskun and H.Stephen,J.Chem.Soc.,1956,4708

    15.G.W.Kenner,B.Lythgoe,A.Todd,and H.Topham,J.Chem.Soc.,
    1943,388
    16.D.J.Brown,in”The Chemistry of Hetercyclic Compounds”,ed
    .A.Weissberger,Interscience,New York,1957
    17.F.G.P.Remfry,J.Chem.Soc.,1911,610
    18.R.Hull,J.Chem.Soc.,1951,2214
    19.Bayer,Ger.Pat.1906,168407
    20.Bayer,Ger.Pat.1906,163136
    21.G.Shaw and R.N.Warrener,J.Chem.Soc.,1958,153
    22.E.Felder,D.Pitre,S.Boveri,and E.B.Grabitz,Chem.Ber.,1967
    ,100,555
    23.O.Ceder and U.Stenhede,Tetrahedron.,1973,29,1585
    24.Barbara Krassowska-Swiebocka,Piotr Lulinski,and Lech Skulski,Synthesis,1995,926
    25.T,Ikemoto et al.,Tetrahedron,2000,56,7915
    26.Peter Gmeiner,and Bernd Bollinger,Synthesis,1995,168
    27.Erik F.Godefroi and Lydia H.Simanyi,J.Chem.Soc.,1963,28,
    1112
    28.J.H.Dewar and G.Shaw,J.Chem.Soc.,1965,1642
    29.Noel J.Cusack,Brian J.Hildick,David H.Robinson,Peter W.Rugg and Gordon Shaw,J.Chem.Soc.Perkin I ,1973,1720
    30.Richard R.Schmidt and Heike Speer,Tetrahedron Letters,1981
    ,22,4259
    31.Cyrille Landreau,David Deniaud,Alain Reliquet,Francoise
    Reliquet,and Claude Meslin,J.Hetercyclic Chem.,2001,38,93
    32.Farbenfabriken Bayer A.G.,J.Org.Chem.,2002,67,1467
    33.Chem.Abstr.,1962,56,14083
    34.Chem.Abstr.,1963,57,10070
    35.Angel Guzman,Moises Romero,and Francisco X.Talamas,J.Org.
    Chem.,1996,61,2470
    36.Peter P.T.Sah and Tsu Sheng Ma,J.Amer.Chem.Soc.,1932,2964
    37.A.N.Terpigorev,G.V.Germanova,and A.G.Bazanov,Russian J.Org.Chem.,1997,33,1712
    38.Arieh Kampf,Conrad J.Pillar,Warren J.Woodford,and Mathias P.Mertes,J.Med.Chem.,1976,19,909
    39.Eric C.Ressner,Phillip Fraher,Marshall S.Edelman,and Mathias.P.Mertes,J.Med.Chem.,1976,19,1
    40.Albert M.van Leusen,Jurjen Wildeman,and Otto H.Oldenziel,
    J.Org.Chem.,1977,42,1153
    41.Edward C.Taylor,and Wendell A.Ehrhart,J.Chem.Soc.,1963,23
    ,1108
    42.Herbert S.Harned,and Nicholas N.T.Samaras,J.Amer.Chem.Soc
    .,1932,54,1
    43.Vladimir Kepe,Marijan Kocevar,Slovenko Polanc,Bojan Verc
    ek,and Miha Tisler,Tetrahedron,1990,46,2081
    44.M.R.Atkinson,G.Shaw,and R.N.Warrener,J.Chem.Soc.,1956,41
    18
    45.G.Shaw.,J.Chem.Soc.,1955,1834

    下載圖示 校內:立即公開
    校外:2004-06-23公開
    QR CODE